Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: A tale of two-hit hypothesis

Journal of Nutritional Biochemistry

Volumn 25, Issue 2, 2014, Pages 232-240

  Periasamy, Srinivasan ^a   Chien, Se Ping ^b   Chang, Po Cheng ^a   Hsu, Dur Zong ^a   Liu, Ming Yie ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

Hepatic fibrosis; Inflammatory cytokines; Leptin; Non alcoholic steatohepatitis; Oxidative stress; Sesame oil

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MALONALDEHYDE; METHIONINE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SESAME SEED OIL; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD SAMPLING; BODY WEIGHT; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

HEPATIC FIBROSIS; INFLAMMATORY CYTOKINES; LEPTIN; NON-ALCOHOLIC STEATOHEPATITIS; OXIDATIVE STRESS; SESAME OIL;

ANIMALS; FATTY LIVER; INFLAMMATION; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; SESAME OIL;

EID: 84892557454     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.10.013     Document Type: Article

References (59)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
2. McCullough A.J. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006, 40:S17-S29.
3. Younossi Z.M., Diehl A.M., Ong J.P. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002, 35:746-752.
4. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
5. Day C., James O. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
6. Lam B.P., Younossi Z.M. Treatment regimens for non-alcoholic fatty liver disease. Ann Hepatol 2009, 8:S51-S59.
7. Povero D., Busletta C., Novo E., di Bonzo L.V., Cannito S., Paternostro C., et al. Liver fibrosis: a dynamic and potentially reversible process. Histol Histopathol 2010, 25:1075-1091.
8. George J., Pera N., Phung N., Leclercq I., Yun Hou J., Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003, 39:756-764.
9. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin-resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183-1192.
10. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005, 115:1343-1351.
11. Chan H.L., de Silva H.J., Leung N.W., Lim S.G., Farrell G.C. Asia-Pacific Working Party on NAFLD.How should we manage patients with non-alcoholic fatty liver disease in 2007?. J Gastroenterol Hepatol 2007, 22:801-808.
12. Khier M.K.S.E., Ishag K.E.A., Yagoub A.E.G.A. Chemical composition and oil characteristics of sesame seed cultivars grown in Sudan research. J Agric Biol Sci 2008, 4:761-766.
13. Yoshida H., Shigezaki J., Takagi S., Kajimoto G. Variation in the composition of various acyl lipid, tocopherols and lignans in sesame seed oil roasted in a microwave oven. J Sci Food Agri 1995, 68:407-415.
14. Sankar D., Sambandam G., Ramakrishna Rao M., Pugalendi K.V. Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils. Clin Chim Acta 2005, 355:97-104.
15. Inoue M., Tazuma S., Kanno K., Hyogo H., Igarashi K., Chayama K. Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model. J Clin Biochem Nutr 2011, 48:161-166.
16. Silva G.H., Hessel G., Coelho K.I., Escanhoela C.A. Steatosis of indeterminate cause in a pediatric group: is it a primary mitochondrial hepatopathy?. Sao Paulo Med J 2011, 129:217-223.
17. Green L.C., Ruiz de Luzuriaga K., Wagner D.A., Rand W., Istfan N., Young V.R., et al. Nitrate biosynthesis in man. Proc Natl Acad Sci U S A 1981, 78:7764-7768.
18. Schattenberg J.M., Nagel M., Kim Y.O., Kohl T., Wörns M.A., Zimmermann T., et al. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. Am J Physiol Gastrointest Liver Physiol 2012, 303:G498-G506.
19. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 1998, 273:5678-5684.
20. Abdelmegeed M.A., Moon K.H., Hardwick J.P., Gonzalez F.J., Song B.J. Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress. Free Radic Biol Med 2009, 47:767-778.
21. Gadang V., Kohli R., Myronovych A., Hui D.Y., Perez-Tilve D., Jaeschke A. MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet. Am J Physiol Endocrinol Metab 2013, 305:E549-E556.
22. Santos S.H., Fernandes L.R., Pereira C.S., Guimarães A.L., de Paula A.M., Campagnole-Santos M.J., et al. Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet. Regul Pept 2012, 178:64-70.
23. López-Prieto J., González-Reimers E., Alemán-Valls M.R., de la Vega-Prieto M.J., Abreu-González P., Pelazas-González R., et al. Iron and proinflammatory cytokines in chronic hepatitis C virus infection. Biol Trace Elem Res 2013, 155:5-10.
24. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112:1785-1788.
25. Tilg H., Moschen A.R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010, 52:1836-1846.
26. Feltenberger J.D., Andrade J.M., Paraíso A., Barros L.O., Filho A.B., Sinisterra R.D., et al. Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice. Hypertension 2013, 62:324-330.
27. Hsu D.Z., Su S.B., Chien S.P., Chiang P.J., Li Y.H., Lo Y.J., et al. Effect of sesame oil on oxidative-stress-associated renal injury in endotoxemic rats: involvement of nitric oxide and proinflammatory cytokines. Shock 2005, 24:276-280.
28. Hsu D.Z., Chen K.T., Chien S.P., Li Y.H., Huang B.M., Chuang Y.C., et al. Sesame oil attenuates acute iron-induced lipid peroxidation-associated hepatic damage in mice. Shock 2006, 26:625-630.
29. Periasamy S., Liu C.T., Hsu D.Z., Liu M.Y. Sesame oil accelerates kidney healing following gentamicin-induced kidney injury in rats. Am J Nephrol 2010, 32:383-392.
30. Schwabe R.F., Brenner D.A. Mechanisms of liver injury. I. TNF-alpha induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006, 290:G583-G589.
31. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
32. Richardson M.M., Jonsson J.R., Powell E.E., Brunt E.M., Neuschwander-Tetri B.A., Bhathal P.S., et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007, 133:80-90.
33. Chavali S.R., Forse R.A. Decreased production of interleukin-6 and prostaglandin E2 associated with inhibition of D-5 desaturation of v6 fatty acids in mice fed safflower oil diets supplemented with sesamol. Prostaglandins Leukot Essent Fatty Acids 1999, 61:347-352.
34. Chavali S.R., Utsunomiya T., Forse R.A. Increased survival after cecal ligation and puncture in mice consuming diets enriched with sesame seed oil. Crit Care Med 2001, 29:140-143.
35. Periasamy S., Hsu D.Z., Chen S.Y., Yang S.S., Chandrasekaran V.R., Liu M.Y. Therapeutic sesamol attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats by inhibiting matrix metalloproteinase-9. Cell Biochem Biophys 2011, 61:327-336.
36. Hsu D.Z., Chen K.T., Li Y.H., Chuang Y.C., Liu M.Y. Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress. Shock 2006, 25:528-532.
37. Hsu D.Z., Chen Y.W., Chu P.Y., Periasamy S., Liu M.Y. Protective effect of 3,4-methylenedioxyphenol (sesamol) on stress-related mucosal disease in rats. Biomed Res Int 2013, 481827.
38. Fishman S., Muzumdar R.H., Atzmon G., Ma X., Yang X., Einstein F.H., et al. Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J 2007, 21:53-60.
39. Petersen K.F., Oral E.A., Dufour S., Befroy D., Ariyan C., Yu C., et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002, 109:1345-1350.
40. Huang W., Dedousis N., Bhatt B.A., O'Doherty R.M. Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. J Biol Chem 2004, 279:21695-21700.
41. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., et al. Role for stearoyl-CoA desaturase-1 in leptin mediated weight loss. Science 2002, 297:240-243.
42. Ntambi J.M., Miyazaki M., Stoehr J.P., Lan H., Kendziorski C.M., Yandell B.S., et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 2002, 99:11482-11486.
43. Ikejima K., Honda H., Yoshikawa M., Hirose M., Kitamura T., Takei Y., et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001, 34:288-297.
44. Marra F. Leptin and liver fibrosis: a matter of fat. Gastroenterology 2002, 122:1529-1532.
45. Wu J., Zern M.A. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000, 35:665-672.
46. Zhang W., Wu R., Zhang F., Xu Y., Liu B., Yang Y., et al. Thiazolidinediones improve hepatic fibrosis by activating the adenosine monophosphate-activated protein kinase (ampk) signaling pathway in rats with non-alcoholic steatohepatitis. Clin Exp Pharmacol Physiol 2012, 10.1111/1440-1681.12020.
47. Yoshida K., Matsuzaki K. Differential regulation of TGF-β/Smad signaling in hepatic stellate cells between acute and chronic liver injuries. Front Physiol 2012, 3:53.
48. Periasamy S., Yang S.S., Chen S.Y., Chang C.C., Liu M.Y. Prophylactic sesame oil attenuates sinusoidal obstruction syndrome by inhibiting matrix metalloproteinase-9 and oxidative stress. JPEN J Parenter Enteral Nutr 2013, 37:529-537.
49. Asokan S., Kumar R.S., Emmadi P., Raghuraman R., Sivakumar N. Effect of oil pulling on halitosis and microorganisms causing halitosis: a randomized controlled pilot trial. J Indian Soc Pedod Prev Dent 2011, 29:90-94.
50. Hsu D.Z., Chien S.P., Li Y.H., Chuang Y.C., Chang Y.C., Liu M.Y. Sesame oil attenuates hepatic lipid peroxidation by inhibiting nitric oxide and superoxide anion generation in septic rats. JPEN J Parenter Enteral Nutr 2008, 32:154-159.
51. Hsu D.Z., Chu P.Y., Liu M.Y. Effect of sesame oil on acidified ethanol- induced gastric mucosal injury in rats. JPEN J Parenter Enteral Nutr 2009, 33:423-427.
52. Chandrasekaran V.R., Wan C.H., Liu L.L., Hsu D.Z., Liu M.Y. Effect of sesame oil against acetaminophen-induced acute oxidative hepatic damage in rats. Shock 2008, 30:217-221.
53. Hou Y.C., Tsai S.Y., Liu I.L., Yu C.P., Chao P.D. Metabolic transformation of sesamol and ex vivo effect on 2,2'-azo-bis(2-amidinopropane)dihydrochloride-induced hemolysis. J Agric Food Chem 2008, 56:9636-9640.
54. Jan K.C., Ho C.T., Hwang L.S. Bioavailability and tissue distribution of sesamol in rat. J Agric Food Chem 2008, 56:7032-7037.
55. Jan K.C., Ho C.T., Hwang L.S. Elimination and metabolism of sesamol, a bioactive compound in sesame oil, in rats. Mol Nutr Food Res 2009, 53(Suppl 1):S36-S43.
56. Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
57. Malinowski S.S., Byrd J.S., Bell A.M., Wofford M.R., Riche D.M. Pharmacologic therapy for nonalcoholic fatty liver disease in adults. Pharmacotherapy 2013, 33:223-242.
58. Afdhal N.H. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?. JAMA 2012, 308:608-616.
59. Hsu D.Z., Liu M.Y. Sesame oil attenuates multiple organ failure and increases survival rate during endotoxemia in rats. Crit Care Med 2002, 30:1859-1862.